Corrigendum: Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength

Daniel Ebrahimi-Fakhari; Ulrich Dillmann; Marina Flotats-Bastardas; Martin Poryo; Hashim Abdul-Khaliq; Mohammed Ghiath Shamdeen; Bernhard Mischo; Michael Zemlin; Sascha Meyer

doi:10.3389/fped.2019.00284

Corrigendum: Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength

Front Pediatr. 2019 Jul 25:7:284. doi: 10.3389/fped.2019.00284. eCollection 2019.

Authors

Daniel Ebrahimi-Fakhari¹, Ulrich Dillmann², Marina Flotats-Bastardas¹, Martin Poryo³, Hashim Abdul-Khaliq³, Mohammed Ghiath Shamdeen⁴, Bernhard Mischo⁴, Michael Zemlin¹, Sascha Meyer¹

Affiliations

¹ Department of Pediatric Neurology, Saarland University Medical Center, Homburg, Germany.
² Department of Neurology, Saarland University Medical Center, Homburg, Germany.
³ Department of Pediatric Cardiology, Saarland University Medical Center, Homburg, Germany.
⁴ Department of Pediatrics, Marienkrankenhaus St. Josef Kohlhof, Neunkirchen, Germany.

Abstract

[This corrects the article DOI: 10.3389/fped.2018.00316.].

Keywords: DMD; Duchenne muscular dystrophy; Translarna; nmDMD; non-ambulatory; pulmonary function test; stop codon read-through therapy; treatment.

Publication types

Published Erratum